A SURVEY REGARDING PROPHYLACTIC USE OF HYDROXYCHLOROQUINE / CHLOROQUINEFOR COVID-19 AMONG HEALTHCARE WORKERS OF PAKISTAN

Authors

  • Wajahat Javed Mirza Rawalpindi Institute of Cardiology, Rawalpindi Pakistan
  • Asim Javed Rawalpindi Institute of Cardiology, Rawalpindi Pakistan
  • Musfireh Siddique Rawalpindi Institute of Cardiology, Rawalpindi Pakistan
  • Humza Azhar Ghauri Rawalpindi Institute of Cardiology, Rawalpindi Pakistan
  • Muhammad Abdus Salam Azad Rawalpindi Institute of Cardiology, Rawalpindi Pakistan
  • Sana Ahmed Rawalpindi Institute of Cardiology, Rawalpindi Pakistan

Keywords:

Chloroquine, Chemoprophylaxis, COVID-19, Hydroxychloroquine

Abstract

Objective: To ascertain the trend of healthcare workers of Pakistan towards prophylactic use of Hydroxychloroquine/Chloroquine.

Study Design: Cross-sectional study.

Place and Duration of Study: Rawalpindi Institute of Cardiology, Rawalpindi, from May 2020 to Jun 2020.

Methodology: The online survey included Health care workers of Prominent Medical Institutes of Pakistan which were selected using non-probability consecutive sampling technique. The respondent‟s identity was kept anonymous. All Healthcare workers, asymptomatic at the time of study were included. Those who were already COVID-19 positive, had any symptoms of COVID-19 or were hospitalized because of any illness were excluded from the study.

Results: Data collected from 500 Healthcare workers showed that 130 (26%) of them used Hydroxychloroquine /Chloroquine for prophylaxis. Hydroxychloroquine was consumed by 119 (91.5%), and Chloroquine by only 11 (8.5%). Furthermore, 61 (47%) used the medication only once, while 46 (35.38%) took stat doses and once weekly. The rest, 15 (11.5%), and 8 (6.1%) took medication at 3 weeks and 2 weeks intervals after stat doses respectively. Out of 130 Healthcare workers, 43 (33.1%) were still using the medication one week, two weeks, and three weeks apart.

Conclusion: In order to establish the prophylactic role of Hydroxychloroquine /Chloroquine effectiveness against COVID-19, clinical trials are direly needed and in the meantime Healthcare Workers of Pakistan need to keep in mind the lack of data regarding the efficacy of these drugs as prophylactic agents and also the potential safety concerns with their use.

Downloads

Download data is not yet available.

Downloads

Published

07-08-2020

Issue

Section

Original Articles

How to Cite

1.
Mirza WJ, Javed A, Siddique M, Ghauri HA, Azad MAS, Ahmed S. A SURVEY REGARDING PROPHYLACTIC USE OF HYDROXYCHLOROQUINE / CHLOROQUINEFOR COVID-19 AMONG HEALTHCARE WORKERS OF PAKISTAN. Pak Armed Forces Med J [Internet]. 2020 Aug. 7 [cited 2024 Nov. 22];70(1):S375-80. Available from: https://pafmj.org/PAFMJ/article/view/4937